NikkiDaskalakisMD

Nephrology • Spring House, PA

Physician

Join to view full profile

Dr. Daskalakis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Daskalakis' full profile

Already have an account?

Office
Early Development Oncology
Spring House, PA
Spring House, PA 19477

Education & Training

Duke University HospitalFellowship, Nephrology, 2003 - 2005
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2000 - 2003
University of Pittsburgh School of MedicineClass of 2000

Certifications & Licensure

NJ State Medical License 2006 - 2025

Publications & Presentations

PubMed

6 citations
Preclinical efficacy of the potent, selective menin-KMT2A inhibitor JNJ-75276617 (bleximenib) in KMT2A- and NPM1-altered leukemias.
Min Chul Kwon, Jan Willem Thuring, Olivier Querolle, Xuedong Dai, Tinne Verhulst
Blood. 2024-09-12
3 citations
First-in-human study of JNJ-67571244, a CD33 × CD3 bispecific antibody, in relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome.
Rupa Narayan, Ana Alfonso Piérola, William B Donnellan, Antonieta Molero Yordi, Maher Abdul-Hay
Clinical and Translational Science. 2024-03-01
14 citations
First-in-human study of JNJ-63709178, a CD123/CD3 targeting antibody, in relapsed/refractory acute myeloid leukemia.
Michael Boyiadzis, Pinkal Desai, Nikki Daskalakis, William Donnellan, Lucille Ferrante
Clinical and Translational Science. 2023-03-01

Press Mentions

Leaders in the Nephrology CommunityFebruary 26th, 2016